Molecular Partners Ag (MOLN) EBT Margin (2021 - 2025)
Historic EBT Margin for Molecular Partners Ag (MOLN) over the last 5 years, with Q3 2025 value amounting to 161.24%.
- Molecular Partners Ag's EBT Margin rose 15036700.0% to 161.24% in Q3 2025 from the same period last year, while for Sep 2025 it was 226.64%, marking a year-over-year increase of 10623302100.0%. This contributed to the annual value of 1080.82% for FY2024, which is 8854846334700.0% up from last year.
- As of Q3 2025, Molecular Partners Ag's EBT Margin stood at 161.24%, which was up 15036700.0% from 1286.17% recorded in Q1 2025.
- Molecular Partners Ag's 5-year EBT Margin high stood at 13822.69% for Q4 2023, and its period low was 579182050.15% during Q1 2024.
- Over the past 5 years, Molecular Partners Ag's median EBT Margin value was 406.33% (recorded in 2021), while the average stood at 59659214.49%.
- Per our database at Business Quant, Molecular Partners Ag's EBT Margin plummeted by 2000000000bps in 2023 and then soared by 2000000000bps in 2025.
- Molecular Partners Ag's EBT Margin (Quarter) stood at 599.86% in 2021, then soared by 110bps to 62.15% in 2022, then skyrocketed by 22141bps to 13822.69% in 2023, then plummeted by -99bps to 144.52% in 2024, then crashed by -212bps to 161.24% in 2025.
- Its EBT Margin stands at 161.24% for Q3 2025, versus 1286.17% for Q1 2025 and 144.52% for Q4 2024.